Proprietary Sequencing Reagents Supply (SMRT Cells, Adapters, Enzymes)

The contract pertains to the manufacture and supply of proprietary, temperature-sensitive reagents including SMRT cells, adapters, and enzymes tailored exclusively for use with the PacBio Revio sequencer platform. These reagents are critical components for high-accuracy long-read sequencing applications and must meet stringent quality and stability requirements to ensure consistent performance in research and diagnostic settings. The work is classified as a subcontract under a Total Small Business Set-Aside, indicating that only small businesses certified by the Small Business Administration are eligible to respond, reinforcing a focus on supporting small business participation in federal scientific procurement. The solicitation is issued by the National Institutes of Health Office of Acquisition and Logistics Operations under the U.S. Department of Health and Human Services, with performance required at a facility in Rockville, Maryland, zip code 20852. The NAICS code 325414 indicates the nature of the work falls within pharmaceutical and biological product manufacturing, specifically highlighting the advanced biotech manufacturing capability needed. The response deadline is set for July 3, 2026, and the posting date of June 24, 2026, provides a limited window for qualified small businesses to prepare and submit their proposals, emphasizing the urgency and precision required for compliance and technical submission.